Divus Laboratories Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 8.33 M
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 41.00 Cr
- Revenue Growth %
- Ebitda
- Net Worth -0.01%
- Total Assets %
About Divus Laboratories
Divus Laboratories Limited (DLL) is a Public Limited Indian Non-Government Company incorporated in India on 06 August 2003 and has a history of 21 years and five months. Its registered office is in Na, Haryana.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 8.33 M.
The company currently has active open charges totaling ₹41.00 Cr.
Rajeev Aggarwal, Bharat Aggarwal, Arunkumar Mittal, and One other member serve as directors at the Company.
Company Details
- LocationNa, Haryana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239HR2003PLC035174
- Company No.
035174
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Divus Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Aggarwal  | Managing Director | 06-Aug-2003 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharat Aggarwal | Director | 06-Aug-2003 | Current |
| Arunkumar Mittal | Director Appointed In Casual Vacancy | 25-Aug-2004 | Current |
| Raman Aggarwal | Director Appointed In Casual Vacancy | 25-Aug-2004 | Current |
Financial Performance of Divus Laboratories.
Divus Laboratories Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Divus Laboratories?
In 2022, Divus Laboratories had a promoter holding of 32.52% and a public holding of 67.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medirin Pharmaceuticals Private LimitedRaman Aggarwal is a mutual person
Casca Remedies Pvt LtdRajeev Aggarwal is a mutual person
Kanha Dreaminfra Private LimitedRaman Aggarwal is a mutual person
Charges (Loans)
₹410.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 41.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2004 | Indian Overseas Bank | ₹41.00 Cr | Open |
How Many Employees Work at Divus Laboratories?
Unlock and access historical data on people associated with Divus Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Divus Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divus Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
